Vicky S. Sabine

Tumor <i>PIK3CA</i> Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data

Dimitrios Zardavas, Luc te Marvelde, Roger L. Milne et al. · Journal of Clinical Oncology · 2018 · 142 citations · Full text

Breast Oncology, Better Idfs, Cancer Pathology +20

Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study

Vicky S. Sabine, Cheryl Crozier, Cassandra Brookes et al. · Journal of Clinical Oncology · 2014 · 134 citations

PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer

Sherene Loi, Stefan Michiels, José Baselga et al. · PLoS ONE · 2013 · 88 citations · Full text

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

E. Jane Macaskill, John M.S. Bartlett, Vicky S. Sabine et al. · Breast Cancer Research and Treatment · 2010 · 55 citations · Full text

Mammalian Target, Rapamycin Inhibitor Everolimus, Breast Oncology +10

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer

Vicky S. Sabine, Andrew H. Sims, E. Jane Macaskill et al. · Breast Cancer Research and Treatment · 2010 · 45 citations · Full text

Breast Oncology, Oncology, Medicine +9